EPILEPSY STUDY CONSORTIUM INC C/O STERLING FOUNDATION MANAGEMENT LLC (EIN 204950952) - Form 990 Financial Analysis & Trantor Score

🔒

Tuckman-Chang Vulnerability Assessment

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2006

Legal Domicile

Principal Officer

JAMES LINTOTT

Phone

7034379720

Tax Period

2024-01-01 to 2024-12-31

EPILEPSY STUDY CONSORTIUM INC C/O STERLING FOUNDATION MANAGEMENT LLC, founded in 2006, is a community nonprofit in the Diseases & Disorders sector that reported $2.4M in total revenue in fiscal year 2018. Expenses of $3.2M exceeded revenue, resulting in a 34% operating deficit.

Mission

ACCELERATING THE DEVELOPMENT OF NEW THERAPIES IN EPILEPSY TO IMPROVE PATIENT CARE THROUGH RESEARCH.

🔒

Trantor Score

Financial Health & Payment Capacity Assessment (FICO Scale: 300–850)

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $512,456

Program Service Revenue $1,919,904

Investment Income $60,181

Other Revenue $0

TOTAL REVENUE $2,492,541

Expense Breakdown

Grants Paid $119,000

Salaries & Benefits $882,849

Fundraising Expenses $0

Program Expenses $2,184,709

Other Expenses $1,219,289

TOTAL EXPENSES $2,221,138

Year-over-Year Comparison

	2024	2023	Change
Revenue	$2,492,541	$3,371,798	-0.3%
Expenses	$2,221,138	$1,701,465	+0.3%
Net Income	$271,403	$1,670,333	-0.8%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$390,953

Total Directors

$422,208

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JAMES LINTOTT ESQ	TREASURER	1.00	Officer Director	$0	$0	$0
MICHAEL SPERLING MD	DIRECTOR	1.00	Director	$4,228	$0	$4,228
JACQUELINE FRENCH MD	PRESIDENT	5.00	Officer Director	$0	$0	$0
DENNIS DLUGOS MD	VICE PRESIDENT	1.00	Officer Director	$0	$0	$0
BREE DIVENTURA	CO-EXECUTIVE DIRECTOR	40.00	Officer Director	$233,530	$7,006	$240,536
DANIEL FRIEDMAN MD	VICE PRESIDENT	1.00	Officer Director	$0	$0	$0
GREGORY KRAUSS MD	DIRECTOR	1.00	Director	$4,875	$0	$4,875
DAWN ELIASHIV MD	DIRECTOR	1.00	Director	$0	$0	$0
PAVEL KLEIN MD	DIRECTOR	1.00	Director	$0	$0	$0
SUDHA KESSLER MD	DIRECTOR	1.00	Director	$0	$0	$0
ROBERT WECHSLER MD PHD	DIRECTOR	1.00	Director	$0	$0	$0
CLAUDE STERIADE MD	DIRECTOR	1.00	Director	$0	$0	$0
MICHAEL GELFAND MD	DIRECTOR	1.00	Director	$22,152	$0	$22,152
JENNIE MINNICK	EXECUTIVE COMMITTEE MEMBER	1.00	Director	$0	$0	$0
MERYL J LOZANO	CO-EXECUTIVE DIRECTOR	40.00	Officer Director	$150,417	$0	$150,417
TRACY L DE VITO	EMPLOYEE	40.00	Highest	$110,004	$0	$110,004

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$2,492,541	$2,221,138	$3,725,581	$271,403
2023	$3,371,798	$1,701,465	$3,454,178	$1,670,333
2022	$2,128,414	$1,917,817	$1,783,845	$210,597
2021	$1,805,835	$1,314,277	$1,573,248	$491,558
2020	$1,622,918	$2,177,935	$1,081,690	$-555,017
2019	$1,989,035	$2,878,662	$1,636,707	$-889,627
2018	$2,414,102	$3,238,445	$2,526,334	$-824,343

EPILEPSY STUDY CONSORTIUM INC C/O STERLING FOUNDATION MANAGEMENT LLC